TREA

86944227 - ONGAVIA

Follow

Information

  • Trademark
  • 86944227
  • Serial Number
    86944227
  • Filing Date
    March 17, 2016
    8 years ago
  • Transaction Date
    December 13, 2018
    6 years ago
  • Status Date
    November 12, 2018
    6 years ago
  • Published for Opposition Date
    August 16, 2016
    8 years ago
  • Location Date
    June 11, 2018
    6 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    EVANKO, PATRICIA MALES
  • Attorney Name
    Matthew O. Brady
    Law Office Assigned Location Code
    N10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
ONGAVIA
Case File Statements
  • GS0051: Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations; sterile ointments; ocular wetting solutions, artificial tears and formulations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body
Case File Event Statements
  • 12/13/2018 - 6 years ago
    32 - UNDELIVERABLE MAIL - NO ACTION TAKEN Type: UNDN
  • 11/13/2018 - 6 years ago
    31 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6
  • 11/12/2018 - 6 years ago
    30 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 6/12/2018 - 6 years ago
    29 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/11/2018 - 6 years ago
    28 - EXTENSION 3 GRANTED Type: EX3G
  • 4/11/2018 - 6 years ago
    27 - EXTENSION 3 FILED Type: EXT3
  • 6/11/2018 - 6 years ago
    26 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 5/24/2018 - 6 years ago
    25 - UNDELIVERABLE MAIL - NO ACTION TAKEN Type: UNDN
  • 5/15/2018 - 6 years ago
    24 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 5/16/2018 - 6 years ago
    23 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/15/2018 - 6 years ago
    22 - NOTICE OF REVIVAL - E-MAILED Type: NREV
  • 5/15/2018 - 6 years ago
    21 - EXTENSION RECEIVED WITH TEAS PETITION Type: TPEX
  • 5/15/2018 - 6 years ago
    20 - PETITION TO REVIVE-GRANTED Type: PETG
  • 5/15/2018 - 6 years ago
    19 - TEAS PETITION TO REVIVE RECEIVED Type: PROA
  • 5/14/2018 - 6 years ago
    18 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6
  • 5/14/2018 - 6 years ago
    17 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 9/28/2017 - 7 years ago
    16 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 9/26/2017 - 7 years ago
    15 - EXTENSION 2 GRANTED Type: EX2G
  • 9/26/2017 - 7 years ago
    14 - EXTENSION 2 FILED Type: EXT2
  • 9/26/2017 - 7 years ago
    13 - TEAS EXTENSION RECEIVED Type: EEXT
  • 4/5/2017 - 7 years ago
    12 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/3/2017 - 7 years ago
    11 - EXTENSION 1 GRANTED Type: EX1G
  • 4/3/2017 - 7 years ago
    10 - EXTENSION 1 FILED Type: EXT1
  • 4/3/2017 - 7 years ago
    9 - TEAS EXTENSION RECEIVED Type: EEXT
  • 10/11/2016 - 8 years ago
    8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 8/16/2016 - 8 years ago
    7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/16/2016 - 8 years ago
    6 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/27/2016 - 8 years ago
    5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/12/2016 - 8 years ago
    4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/27/2016 - 8 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/22/2016 - 8 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/21/2016 - 8 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP